• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home The Classics Cardiology Classics

The SEPSISPAM trial: Mean arterial pressure targets in septic shock [Classics Series]

byDeepti Shroff Karhade
June 17, 2022
in Cardiology Classics, The Classics
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

This study summary is an excerpt from the book 2 Minute Medicine’s The Classics in Medicine: Summaries of the Landmark Trials

1. This trial demonstrated that mortality did not differ with a mean arterial pressure (MAP) target of 80-85mmHg (36.6%) as compared to 65-70mmHg (34.0%) in septic shock patients.

2. Incidence of new atrial fibrillation was significantly increased in the 80-85mmHg MAP threshold group.

Original Date of Publication: April 2014

Study Rundown: The Sepsis and Mean Arterial Pressure (SEPSISPAM) trial compared a resuscitation target MAP of 80-85mmHg to a target of 65-70mmHg in septic shock patients. The primary end point measured was all-cause mortality measured at 28 days after resuscitation, which did not differ significantly between groups. Secondary outcomes of 90-day mortality and serious adverse events also did not differ between groups. Although, new onset atrial fibrillation and need for renal-replacement in chronic hypertension patients was increased in the 80-85mmHg target group. The limitations of the present study included variations in MAP during treatment as well as differential use of glucocorticoids between patients. Although, MAP fluctuation was not significant enough to warrant a protocol violation. The SEPSISPAM trial was the first to demonstrate that low versus high MAP targets in septic shock patients do not impact mortality following resuscitation.

Click to read the study in NEJM

In-Depth [randomized control trial]: The SEPISPAM trial included patients who required resuscitation for septic shock, randomizing participants into a target MAP of 80-85 mmHg (n = 142) as compared to 65-70 mmHg (n = 132). The primary outcome of all-cause mortality at 28 days did not differ in the high target group as compared to the low target group (HR 1.07; 95%CI 0.84-1.38), which was sustained at 90 days (HR 1.04; 95%CI 0.83-1.30). Conversely, the high threshold groups had significantly higher rates of new atrial fibrillation (p = 0.02) and need for renal-replacement therapy in participants with chronic hypertension (p = 0.04). Serious adverse events did not differ between groups (p = 0.64).

RELATED REPORTS

#VisualAbstract: Catheter cryoballoon ablation is superior in rhythm control for paroxysmal atrial fibrillation

Higher blood pressure targets do not improve outcomes in comatose patients

#VisualAbstract: Intravenous vitamin C increases mortality and organ dysfunction in sepsis patients

Asfar P, Meziani F, Hamel J-F, Grelon F, Megarbane B, Anguel N, et al. High versus Low Blood-Pressure Target in Patients with Septic Shock. New England Journal of Medicine. 2014 Apr 24;370(17):1583–93.

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: atrial fibrillaionmean arterial pressureresuscitationseptic shock
Previous Post

High burden of persistent symptoms seen in patients after COVID-19 recovery

Next Post

Anti-tau antibody Semorinemab not shown to slow clinical progression of Alzheimer’s disease

RelatedReports

#VisualAbstract: Catheter cryoballoon ablation is superior in rhythm control for paroxysmal atrial fibrillation
StudyGraphics

#VisualAbstract: Catheter cryoballoon ablation is superior in rhythm control for paroxysmal atrial fibrillation

November 22, 2022
Cardiology

Higher blood pressure targets do not improve outcomes in comatose patients

October 25, 2022
#VisualAbstract: Intravenous vitamin C increases mortality and organ dysfunction in sepsis patients
StudyGraphics

#VisualAbstract: Intravenous vitamin C increases mortality and organ dysfunction in sepsis patients

July 7, 2022
Hypotonic IVF linked to increased risk of hyponatremia
Emergency

Intravenous fluid restriction does not improve septic shock outcomes

June 27, 2022
Next Post
Genetic risk assessment for Alzheimer’s disease does not increase anxiety, depression or stress

Anti-tau antibody Semorinemab not shown to slow clinical progression of Alzheimer’s disease

Social networks play key roles in parental vaccination decisions

The ZF2001 vaccine is safe and effective at preventing COVID-19 in adults

Thrombophilia-associated stillbirth risk appears limited to factor V Leiden

2 Minute Medicine Rewind June 20, 2022

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Dual antiplatelet therapy discontinued 9 months after percutaneous coronary intervention associated with improved morbidity and mortality
  • Concordance of diagnosis of autism spectrum disorder made by pediatricians vs multidisciplinary specialist teams
  • Cystatin C-based equation without race or sex improves accuracy of GFR estimation
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options